Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactoferrin Counteracts This Effect. [electronic resource]
Producer: 20190219Description: 62-67.e1 p. digitalISSN:- 1097-6833
- Administration, Oral
- Dietary Supplements
- Enterocolitis, Necrotizing -- epidemiology
- Gastric Acid
- Histamine H2 Antagonists -- adverse effects
- Humans
- Infant, Newborn
- Infant, Premature
- Infant, Very Low Birth Weight
- Intensive Care Units, Neonatal
- Italy
- Lacticaseibacillus rhamnosus
- Lactoferrin -- administration & dosage
- New Zealand
- Probiotics -- administration & dosage
- Proton Pump Inhibitors -- adverse effects
- Risk Factors
- Sepsis -- epidemiology
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.